BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27388747)

  • 1. AKT1 Activation is Obligatory for Spontaneous BCC Tumor Growth in a Murine Model that Mimics Some Features of Basal Cell Nevus Syndrome.
    Kim AL; Back JH; Zhu Y; Tang X; Yardley NP; Kim KJ; Athar M; Bickers DR
    Cancer Prev Res (Phila); 2016 Oct; 9(10):794-802. PubMed ID: 27388747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview.
    Bellei B; Caputo S; Carbone A; Silipo V; Papaccio F; Picardo M; Eibenschutz L
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
    Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
    J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.
    Chaudhary SC; Tang X; Arumugam A; Li C; Srivastava RK; Weng Z; Xu J; Zhang X; Kim AL; McKay K; Elmets CA; Kopelovich L; Bickers DR; Athar M
    Oncotarget; 2015 Nov; 6(34):36789-814. PubMed ID: 26413810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.
    Saran A
    Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
    Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
    Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocytes from Gorlin Syndrome-induced pluripotent stem cells are resistant against UV radiation.
    Morita N; Onodera S; Nakamura Y; Nakamura T; Takahashi SI; Nomura T; Azuma T
    Med Mol Morphol; 2021 Jun; 54(2):69-78. PubMed ID: 32816116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Stability in Syndromic Basal Cell Carcinoma.
    Chiang A; Jaju PD; Batra P; Rezaee M; Epstein EH; Tang JY; Sarin KY
    J Invest Dermatol; 2018 May; 138(5):1044-1051. PubMed ID: 29111235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the histopathologic features of basal cell carcinomas in pediatric patients with basal cell nevus syndrome.
    Nguyen CV; Rubin AI; Smith A; Castelo-Soccio L
    J Cutan Pathol; 2021 Mar; 48(3):390-395. PubMed ID: 33063358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
    Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
    Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
    Gache Y; Brellier F; Rouanet S; Al-Qaraghuli S; Goncalves-Maia M; Burty-Valin E; Barnay S; Scarzello S; Ruat M; Sevenet N; Avril MF; Magnaldo T
    PLoS One; 2015; 10(12):e0145369. PubMed ID: 26694869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct non-clock-like signatures of the basal cell carcinomas from three sisters with a lethal Gorlin-Goltz syndrome.
    Ye L; Wang L; Peng K; Fang O; Tian Z; Li C; Fu X; Chen Q; Chen J; Luan J; Zhang Z; Zhang Q
    BMC Med Genomics; 2022 Aug; 15(1):172. PubMed ID: 35932013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome.
    Gielen RCAM; Reinders MGHC; Koillinen HK; Paulussen ADC; Mosterd K; van Geel M
    J Hum Genet; 2018 Sep; 63(9):965-969. PubMed ID: 29930296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.
    Valin A; Barnay-Verdier S; Robert T; Ripoche H; Brellier F; Chevallier-Lagente O; Avril MF; Magnaldo T
    PLoS One; 2009; 4(3):e4818. PubMed ID: 19287498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
    Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
    Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevoid Basal Cell Carcinoma Syndrome:
    Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
    Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
    Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
    Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.